SLC28A3
Solute carrier family 28 member 3
Also known as: CNT3, S28A3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HAS3
- Gene
- SLC28A3
- Ensembl
- ENSG00000197506
- Chromosome
- 9
- Canonical length
- 691 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
Nucleoside transporters, such as SLC28A3, regulate multiple cellular processes, including neurotransmission, vascular tone, adenosine concentration in the vicinity of cell surface receptors, and transport and metabolism of nucleoside drugs. SLC28A3 shows broad specificity for pyrimidine and purine nucleosides (Ritzel et al., 2001 [PubMed 11032837]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
691 residues, UniProt reviewed canonical sequence.
>Q9HAS3|SLC28A3
1 MELRSTAAPR AEGYSNVGFQ NEENFLENEN TSGNNSIRSR AVQSREHTNT KQDEEQVTVE
61 QDSPRNREHM EDDDEEMQQK GCLERRYDTV CGFCRKHKTT LRHIIWGILL AGYLVMVISA
121 CVLNFHRALP LFVITVAAIF FVVWDHLMAK YEHRIDEMLS PGRRLLNSHW FWLKWVIWSS
181 LVLAVIFWLA FDTAKLGQQQ LVSFGGLIMY IVLLFLFSKY PTRVYWRPVL WGIGLQFLLG
241 LLILRTDPGF IAFDWLGRQV QTFLEYTDAG ASFVFGEKYK DHFFAFKVLP IVVFFSTVMS
301 MLYYLGLMQW IIRKVGWIML VTTGSSPIES VVASGNIFVG QTESPLLVRP YLPYITKSEL
361 HAIMTAGFST IAGSVLGAYI SFGVPSSHLL TASVMSAPAS LAAAKLFWPE TEKPKITLKN
421 AMKMESGDSG NLLEAATQGA SSSISLVANI AVNLIAFLAL LSFMNSALSW FGNMFDYPQL
481 SFELICSYIF MPFSFMMGVE WQDSFMVARL IGYKTFFNEF VAYEHLSKWI HLRKEGGPKF
541 VNGVQQYISI RSEIIATYAL CGFANIGSLG IVIGGLTSMA PSRKRDIASG AVRALIAGTV
601 ACFMTACIAG ILSSTPVDIN CHHVLENAFN STFPGNTTKV IACCQSLLSS TVAKGPGEVI
661 PGGNHSLYSL KGCCTLLNPS TFNCNGISNT FLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC28A3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 11
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 32 nTPM
- salivary gland: 12 nTPM
- skin: 9.4 nTPM
- bone marrow: 8.9 nTPM
- breast: 8.3 nTPM
- pancreas: 7.7 nTPM
Single-cell type
- choroid plexus epithelial cells: 139 nCPM
- pancreatic duct cells: 135 nCPM
- mesothelial cells: 118 nCPM
- fallopian secretory cells: 67 nCPM
- esophageal apical cells: 61 nCPM
- salivary acinar cells: 60 nCPM
Immune cell
- intermediate monocyte: 0.5 nTPM
- NK-cell: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- choroid plexus: 47 nTPM
- midbrain: 2.1 nTPM
- medulla oblongata: 2 nTPM
- hippocampal formation: 1.8 nTPM
- spinal cord: 0.8 nTPM
- thalamus: 0.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.24
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.07
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- nucleoside transmembrane transport
- purine nucleobase transmembrane transport
- purine nucleoside transmembrane transport
- pyrimidine-containing compound transmembrane transport
- uridine transmembrane transport
- xenobiotic metabolic process
- xenobiotic transmembrane transport
- pyrimidine nucleoside transport
Molecular functions
- nucleoside:sodium symporter activity
- purine nucleobase transmembrane transporter activity
- pyrimidine- and adenosine-specific:sodium symporter activity
- uridine transmembrane transporter activity
- purine-specific nucleoside:sodium symporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Concentrative nucleoside transporter N-terminal domain
- Concentrative nucleoside transporter
- Nucleoside transporter/FeoB GTPase, Gate domain
- Concentrative nucleoside transporter C-terminal domain
- Concentrative nucleoside transporter, metazoan/bacterial
- Na+ dependent nucleoside transporter N-terminus
- Na+ dependent nucleoside transporter C-terminus
- Nucleoside recognition
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC28A3 as an antibody target. Whether an autoantibody or antibody against SLC28A3 could matter depends on whether native SLC28A3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC28A3 is annotated at the cell surface, where native SLC28A3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC28A3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...